How Drug Prices Work | WSJ

Overview: The pricing of prescription drugs is not straightforward; it encompasses a variety of stakeholders, each influencing the price at different stages of the supply chain.
Factors: Drug pricing reflects factors such as research and development costs, regulatory approvals, marketing, and the involvement of various intermediaries.

Pharmaceutical Companies (Manufacturers): Responsible for drug research, development, and manufacture. They initially set the drug's list price based on anticipated market conditions and R&D costs.
Wholesalers: They purchase drugs from manufacturers, handle distribution and logistics, and supply pharmacies. They play a critical role in ensuring drugs are available locally.
Pharmacy Benefit Managers (PBMs): These entities negotiate prices and help determine drug formulary placement, significantly affecting drug costs to patients.
Insurance Companies: They provide coverage for medications and negotiate prices with PBMs. Insurance plans shape patient access and out-of-pocket costs for medications through their formularies.
Consumers (Patients): The end-users who ultimately pay for the drugs, either through insurance or out-of-pocket expenses. Patients' access to affordable medications can be directly influenced by how the pricing structure is set up.

Initial Drug Development: Pharmaceutical companies invest heavily in R&D, a process that can take over a decade and cost billions before a drug reaches the market.
List Price Complexity: The list price is often substantially higher than the net price after discounts, rebates, and negotiations are applied. This discrepancy complicates pricing transparency for both patients and insurers.

Definition: PBMs are intermediaries that manage drug benefits for health insurers, employers, and government programs. They play a pivotal role in controlling drug costs and managing the pharmacy supply chain.
Functions of PBMs:
- Negotiate Rebates: They negotiate rebates with manufacturers, aiming to reduce the costs of drugs for the insurance parties they represent.
- Formulary Management: PBMs create and manage drug formularies, determining which drugs are covered, how they are tiered, and the cost-sharing for patients. This affects patients' access based on their insurance plan.
- Retail Pharmacy Relations: PBMs may have agreements with retail pharmacies that can influence which pharmacies patients choose based on co-pays and network status.
Rebates: Often a portion of the negotiated rebate is retained by the PBM, impacting their profits and creating concerns about whether savings are passed on to consumers adequately.

What is a Formulary?: A formulary is a comprehensive list of approved medications that are covered by a health insurance plan, systematically categorized to guide prescribing and dispensing.
Tier Definitions:
- Higher Tiers: Drugs that cost patients less out-of-pocket, typically reflecting higher manufacturer rebates.
- Lower Tiers: These drugs may cost patients more at the point of sale, indicating either less demand or lower manufacturer discounts.
Importance of Formulary Position: How a drug is positioned within a formulary can heavily influence its usage, guiding doctors' prescribing patterns and patients' financial burdens.

Hypothetical Example:
- Drug List Price: $100
- Negotiated PBM Rebate: $50
- PBM profit from rebate: $10
- Amount passed to insurance: $40
- Outcome: With effective negotiation, the drug's formulary position is improved, resulting in a lower co-pay for patients, increasing accessibility and sales for the pharmaceutical company.

Rising Drug Prices: Pharmaceutical companies cite the pressure of rebates demanded by PBMs as a justification for increasing list prices over time, asserting it is necessary to maintain profitability.
Illustrative Chart: The rising price trend of drugs, such as Humalog, is exemplified by increases that often correlate with higher rebate structures.

PBMs' Stance: PBMs argue that their role in negotiating rebates and managing formularies helps lower overall drug costs for payers and can lead to lower insurance premiums for patients.
Statement by PBMs: They emphasize that their involvement is essential to providing patients necessary access to medications at reduced costs.